Santos AA, Silva JP, Silva Lda F, Sousa AG, Piotto RF, Baumgratz JF. Rev Bras Cir Cardiovasc. 2014;29(4):606-21. doi: 10.5935/1678-9741.20140114. Review. English, Portuguese. PMID: 25714216 http://www.ncbi.nlm.nih.gov/pubmed/25714216

The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a “real life” retrospective multicenter experience of the Rete Ematologica Pugliese (REP). Mazza P, Minoia C, Melpignano A, Polimeno G, Cascavilla N et al. Ann Hematol. 2016 Jan;95(2):239-44. doi: 10.1007/s00277-015-2556-z. Epub 2015 Nov 24. PMID: 26596973 https://www.ncbi.nlm.nih.gov/pubmed/26596973

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C et al. Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8. Epub 2016 Apr 18. PMID: 27103127 https://www.ncbi.nlm.nih.gov/pubmed/27103127

Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. Wang Y, Wang Z, Wu L, Zhang J, Wang J, Yan L. Annals of Hematology 2013: 92(12) 1695-99. PMID: 23778995 http://www.ncbi.nlm.nih.gov/pubmed/23778995

Eltrombopag for the treatment of aplastic anemia: current perspectives Su Han Lum, John D Grainger Drug Des Devel Ther. 2016; 10: 2833–2843. Published online 2016 Sep 13. doi: 10.2147/DDDT.S95715 PMCID: 5028092 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028092/

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled Trial. Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L et al. Lancet 2009 21;373(9664):641-8. doi: 10.1016/S0140-6736(09)60402-5. PMID: 19231632 http://www.ncbi.nlm.nih.gov/pubmed/19231632

2017 © Copyright - Bloodless

Interaktiv